EX-10.1 2 dex101.htm AMENDMENT NO. 1 TO EXCLUSIVE SALES DISTRIBUTION AGREEMENT CONFIDENTIAL AMENDMENT NO. 1 TO EXCLUSIVE SALES DISTRIBUTION AGREEMENTExclusive Sales Distribution Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionTHIS AMENDMENT NO. 1 (“Amendment”) to that certain Exclusive Sales Distribution Agreement, dated July 1, 2004 (“Agreement”), is dated September 30, 2005 (“Amendment Effective Date”), and is between Orthovita, Inc., a Pennsylvania corporation with principal offices at 45 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”), and Angiotech BioMaterials Corp. (formerly known as Cohesion Technologies, Inc.), a Delaware corporation with principal offices at 2500 Faber Place, Palo Alto, California 94303 (“Cohesion”).
AMENDMENT NO. 1 TO EXCLUSIVE SALES DISTRIBUTION AGREEMENTExclusive Sales Distribution Agreement • November 9th, 2005 • Orthovita Inc • Surgical & medical instruments & apparatus • California
Contract Type FiledNovember 9th, 2005 Company Industry JurisdictionTHIS AMENDMENT NO. 1 (“Amendment”) to that certain Exclusive Sales Distribution Agreement, dated July 1, 2004 (“Agreement”), is dated September 30, 2005 (“Amendment Effective Date”), and is between Orthovita, Inc., a Pennsylvania corporation with principal offices at 45 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”), and Angiotech BioMaterials Corp. (formerly known as Cohesion Technologies, Inc.), a Delaware corporation with principal offices at 2500 Faber Place, Palo Alto, California 94303 (“Cohesion”).